Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361243886> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4361243886 abstract "<div>Abstract<p>Ovarian cancer is a lethal gynecologic malignancy that may benefit from new therapies that block key paracrine pathways involved in tumor-stromal interactions and tumor vascularity. It was recently shown that matrix metalloprotease-1 (MMP1) activation of the G protein–coupled receptor protease-activated receptor-1 (PAR1) is an important stimulator of angiogenesis and metastasis in peritoneal mouse models of ovarian cancer. In the present study, we tested the hypothesis that MMP1-PAR1 promotes angiogenesis through its paracrine control of angiogenic chemokine receptors. We found that MMP1-PAR1 activation induces the secretion of several angiogenic factors from ovarian carcinoma cells, most prominently interleukin (IL)-8, growth-regulated oncogene-α (GRO-α), and monocyte chemoattractant protein-1. The secreted IL-8 and GRO-α acts on endothelial CXCR1/2 receptors in a paracrine manner to cause robust endothelial cell proliferation, tube formation, and migration. A cell-penetrating pepducin, X1/2pal-i3, which targets the conserved third intracellular loop of both CXCR1 and CXCR2 receptors, significantly inhibited endothelial cell proliferation, tube formation, angiogenesis, and ovarian tumor growth in mice. Matrigel plugs mixed with MMP1-stimulated, OVCAR-4–conditioned media showed a dramatic 33-fold increase in blood vessel formation in mice. The X1/2pal-i3 pepducin completely inhibited MMP1-dependent angiogenesis compared with a negative control pepducin or vehicle. Conversely, a vascular endothelial growth factor–directed antibody, Avastin, suppressed angiogenesis in mice but, as expected, was unable to inhibit IL-8 and GRO-α–dependent endothelial tube formation <i>in vitro</i>. These studies identify a critical MMP1-PAR1-CXCR1/2 paracrine pathway that might be therapeutically targeted for ovarian cancer treatment. Cancer Res; 70(14); 5880–90. ©2010 AACR.</p></div>" @default.
- W4361243886 created "2023-03-31" @default.
- W4361243886 creator A5005321402 @default.
- W4361243886 creator A5006545278 @default.
- W4361243886 creator A5010239244 @default.
- W4361243886 creator A5018439593 @default.
- W4361243886 creator A5068666232 @default.
- W4361243886 creator A5071203279 @default.
- W4361243886 creator A5077617262 @default.
- W4361243886 date "2023-03-30" @default.
- W4361243886 modified "2023-10-17" @default.
- W4361243886 title "Data from Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy" @default.
- W4361243886 doi "https://doi.org/10.1158/0008-5472.c.6500159.v1" @default.
- W4361243886 hasPublicationYear "2023" @default.
- W4361243886 type Work @default.
- W4361243886 citedByCount "0" @default.
- W4361243886 crossrefType "posted-content" @default.
- W4361243886 hasAuthorship W4361243886A5005321402 @default.
- W4361243886 hasAuthorship W4361243886A5006545278 @default.
- W4361243886 hasAuthorship W4361243886A5010239244 @default.
- W4361243886 hasAuthorship W4361243886A5018439593 @default.
- W4361243886 hasAuthorship W4361243886A5068666232 @default.
- W4361243886 hasAuthorship W4361243886A5071203279 @default.
- W4361243886 hasAuthorship W4361243886A5077617262 @default.
- W4361243886 hasBestOaLocation W43612438862 @default.
- W4361243886 hasConcept C126322002 @default.
- W4361243886 hasConcept C134018914 @default.
- W4361243886 hasConcept C16930146 @default.
- W4361243886 hasConcept C170493617 @default.
- W4361243886 hasConcept C203014093 @default.
- W4361243886 hasConcept C2776107976 @default.
- W4361243886 hasConcept C2778608917 @default.
- W4361243886 hasConcept C2780394083 @default.
- W4361243886 hasConcept C3020616263 @default.
- W4361243886 hasConcept C502942594 @default.
- W4361243886 hasConcept C71924100 @default.
- W4361243886 hasConcept C7876069 @default.
- W4361243886 hasConcept C86803240 @default.
- W4361243886 hasConcept C95444343 @default.
- W4361243886 hasConceptScore W4361243886C126322002 @default.
- W4361243886 hasConceptScore W4361243886C134018914 @default.
- W4361243886 hasConceptScore W4361243886C16930146 @default.
- W4361243886 hasConceptScore W4361243886C170493617 @default.
- W4361243886 hasConceptScore W4361243886C203014093 @default.
- W4361243886 hasConceptScore W4361243886C2776107976 @default.
- W4361243886 hasConceptScore W4361243886C2778608917 @default.
- W4361243886 hasConceptScore W4361243886C2780394083 @default.
- W4361243886 hasConceptScore W4361243886C3020616263 @default.
- W4361243886 hasConceptScore W4361243886C502942594 @default.
- W4361243886 hasConceptScore W4361243886C71924100 @default.
- W4361243886 hasConceptScore W4361243886C7876069 @default.
- W4361243886 hasConceptScore W4361243886C86803240 @default.
- W4361243886 hasConceptScore W4361243886C95444343 @default.
- W4361243886 hasLocation W43612438861 @default.
- W4361243886 hasLocation W43612438862 @default.
- W4361243886 hasOpenAccess W4361243886 @default.
- W4361243886 hasPrimaryLocation W43612438861 @default.
- W4361243886 hasRelatedWork W1963903983 @default.
- W4361243886 hasRelatedWork W1992804143 @default.
- W4361243886 hasRelatedWork W2033472167 @default.
- W4361243886 hasRelatedWork W2034583712 @default.
- W4361243886 hasRelatedWork W2063619316 @default.
- W4361243886 hasRelatedWork W2074821979 @default.
- W4361243886 hasRelatedWork W2108004598 @default.
- W4361243886 hasRelatedWork W2169133530 @default.
- W4361243886 hasRelatedWork W2169225653 @default.
- W4361243886 hasRelatedWork W2327114013 @default.
- W4361243886 isParatext "false" @default.
- W4361243886 isRetracted "false" @default.
- W4361243886 workType "article" @default.